AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,754.00p
   
  • Change Today:
    146.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.64m
  • Volume: 2,160,082
  • Market Cap: £166,756m
  • RiskGrade: 123

Latest Deals

Traded Action Notifier PriceAmountValue
30-Apr-25 Buy Karen Knudsen 5,376.72p 1,400 £75,274.07

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
30-Apr-25 Buy Karen Knudsen 5,376.72p 1,400 £75,274.07

Director Shareholdings

Notifier Holding Value*
Pascal Soriot 882,891 £94,946,098
Aradhana Sarin 118,367 £12,729,187
Marcus Wallenberg 60,028 £6,455,411
Michel Demare 10,000 £1,075,400
Philip A J Broadley 8,025 £863,008
Tony Mok 3,500 £376,390
Sheri McCoy 1,736 £186,689
Diana Layfield 1,400 £150,556
Karen Knudsen 1,400 £150,556
Euan Ashley 1,150 £123,671
Nazneen Rahman 1,017 £109,368
Anna Manz 487 £52,372

Major Shareholders

Notifier** Holding Value*
BlackRock, Inc 100,885,181 £10,849,192,365
Oddo Meriten Asset Management SA 100,885,181 £10,849,192,365
The Capital Group Companies, Inc. 77,540,115 £8,338,663,967
Wellington Management Company LLP 65,118,411 £7,002,833,919
Investor AB 51,587,810 £5,547,753,087

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,754.00p
Change Today 146.00p
% Change 1.38 %
52 Week High 13,276.00
52 Week Low 9,667.00
Volume 2,160,082
Shares Issued 1,550.64m
Market Cap £166,756m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.64% below the market average94.64% below the market average94.64% below the market average94.64% below the market average94.64% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
14.21% below the market average14.21% below the market average14.21% below the market average14.21% below the market average14.21% below the market average
41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average
Income
65.99% below the market average65.99% below the market average65.99% below the market average65.99% below the market average65.99% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
85.93% above the market average85.93% above the market average85.93% above the market average85.93% above the market average85.93% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 4
Sell 0
Strong Sell 1
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 02-May-2025

Time Volume / Share Price
15:36 0 @ 10,740.00p
15:36 0 @ 10,740.00p
15:47 0 @ 10,768.00p
15:30 29 @ 10,738.00p
15:30 0 @ 10,732.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page